| Primary |
| Drug Use For Unknown Indication |
59.3% |
| Benign Prostatic Hyperplasia |
8.8% |
| Hypertension |
6.3% |
| Prostatitis |
2.9% |
| Pain |
2.4% |
| Product Used For Unknown Indication |
2.2% |
| Depression |
1.7% |
| Epilepsy |
1.7% |
| Urinary Tract Infection |
1.7% |
| Anxiety |
1.5% |
| Dyslipidaemia |
1.5% |
| Renal Transplant |
1.5% |
| Urinary Retention |
1.5% |
| Hypothyroidism |
1.2% |
| Prostatic Adenoma |
1.2% |
| Angina Pectoris |
1.0% |
| Benign Prostatic Hypertrophy |
1.0% |
| Insomnia |
1.0% |
| Pulmonary Embolism |
1.0% |
| Bronchitis |
0.7% |
|
| Thrombocytopenia |
11.6% |
| Rhabdomyolysis |
8.7% |
| Atrial Fibrillation |
7.2% |
| Urinary Retention |
7.2% |
| Psoriasis |
5.8% |
| Renal Failure Acute |
5.8% |
| Toxic Skin Eruption |
5.8% |
| Death |
4.3% |
| Myocardial Infarction |
4.3% |
| Osteonecrosis |
4.3% |
| Pancreatitis |
4.3% |
| Pyrexia |
4.3% |
| Rash Maculo-papular |
4.3% |
| Somnolence |
4.3% |
| Agranulocytosis |
2.9% |
| Eosinophilia |
2.9% |
| Interstitial Lung Disease |
2.9% |
| Iris Disorder |
2.9% |
| Lichenoid Keratosis |
2.9% |
| Macular Degeneration |
2.9% |
|
| Secondary |
| Drug Use For Unknown Indication |
34.8% |
| Product Used For Unknown Indication |
12.0% |
| Hypertension |
10.6% |
| Benign Prostatic Hyperplasia |
6.2% |
| Angina Pectoris |
4.5% |
| Cardiac Failure |
3.8% |
| Pain |
3.6% |
| Diabetes Mellitus |
2.7% |
| Bronchitis |
2.6% |
| Gastrooesophageal Reflux Disease |
2.6% |
| Infection |
2.4% |
| Insomnia |
2.4% |
| Type 2 Diabetes Mellitus |
2.1% |
| Anxiety |
1.5% |
| Atrial Fibrillation |
1.5% |
| Prostate Cancer |
1.5% |
| Urinary Retention |
1.5% |
| Essential Hypertension |
1.4% |
| Epilepsy |
1.2% |
| Hypokalaemia |
1.2% |
|
| Orthostatic Hypotension |
9.9% |
| Renal Failure |
9.9% |
| Thrombocytopenia |
8.9% |
| Rhabdomyolysis |
7.9% |
| Haematoma |
6.9% |
| Malaise |
6.9% |
| Pancreatitis |
6.9% |
| Renal Failure Acute |
5.0% |
| Somnolence |
5.0% |
| Toxic Skin Eruption |
4.0% |
| Vomiting |
4.0% |
| White Blood Cell Count Increased |
4.0% |
| Metabolic Alkalosis |
3.0% |
| Prostate Cancer |
3.0% |
| Pulmonary Alveolar Haemorrhage |
3.0% |
| Tendon Rupture |
3.0% |
| Thrombosis |
3.0% |
| Agranulocytosis |
2.0% |
| Cholestasis |
2.0% |
| Coma |
2.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
29.6% |
| Product Used For Unknown Indication |
17.0% |
| Hypertension |
9.8% |
| Benign Prostatic Hyperplasia |
6.0% |
| Pain |
4.0% |
| Depression |
3.8% |
| Prophylaxis |
3.2% |
| Atrial Fibrillation |
2.9% |
| Hiv Infection |
2.4% |
| Ill-defined Disorder |
2.4% |
| Thrombosis Prophylaxis |
2.2% |
| Anxiety |
2.2% |
| Diabetes Mellitus |
2.2% |
| Renal Transplant |
2.0% |
| Hypercholesterolaemia |
1.8% |
| Prostatic Adenoma |
1.8% |
| Parkinson's Disease |
1.8% |
| Dyslipidaemia |
1.6% |
| Insomnia |
1.6% |
| Multiple Sclerosis |
1.6% |
|
| Vomiting |
10.2% |
| Renal Failure Acute |
9.8% |
| Thrombocytopenia |
9.8% |
| Renal Failure |
8.3% |
| Weight Decreased |
6.3% |
| Somnolence |
5.4% |
| Urinary Retention |
5.4% |
| Urinary Tract Infection |
5.4% |
| Myocardial Infarction |
4.4% |
| Progressive Multifocal Leukoencephalopathy |
3.9% |
| Pyrexia |
3.9% |
| Rash |
3.4% |
| Syncope |
3.4% |
| Toxic Skin Eruption |
3.4% |
| Jaundice |
2.9% |
| Neutropenia |
2.9% |
| Septic Shock |
2.9% |
| Tremor |
2.9% |
| Weight Increased |
2.9% |
| Cytolytic Hepatitis |
2.4% |
|
| Interacting |
| Abdominal Hernia |
28.6% |
| Anxiety |
14.3% |
| Benign Prostatic Hyperplasia |
14.3% |
| Chronic Obstructive Pulmonary Disease |
14.3% |
| Depression |
14.3% |
| Hypertension |
14.3% |
|
| Orthostatic Hypotension |
50.0% |
| Syncope |
50.0% |
|
